Prostate carcinoma treatment

Details Prostate carcinoma treatment Prostate carcinoma treatment

1974-05-01

1976-08-17

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

A61K 31695

Patent

active

039755215

ABSTRACT:
Patients suffering from prostate carcinoma obtain a palliative action upon administration of 2,6-cis-diphenylhexamethylcyclotetrasiloxane.

REFERENCES:
patent: 2934472 (1960-04-01), May
patent: 3382150 (1968-05-01), Grass et al.

Affiliated with

Also associated with

Rating

Prostate carcinoma treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostate carcinoma treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate carcinoma treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1486655